Gilead allies with targeted drug startup Tentarix in latest research bet August 15, 2023 San Francisco Biotechnology Network News News, Syndication Comments Off on Gilead allies with targeted drug startup Tentarix in latest research bet San Diego-based Tentarix will receive $66 million in cash and equity from Gilead, which holds an option to acquire up to three of the company’s subsidiaries. Click here to view original post